Effects of Conical Positive Expiratory Pressure Mask Application During Exercise Training on Pulmonary Rehabilitation Outcomes in Moderate to Severe COPD Cases: A Randomized Controlled Trial

  • Abstract
  • Literature Map
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon
Take notes icon Take Notes

BackgroundThe use of positive expiratory pressure (PEP), which includes conical-PEP breathing, has been proposed for use during exercise among patients with chronic obstructive pulmonary disease (COPD) to reduce dynamic hyperinflation (DH) and improve exercise capacity. However, evidence on the effects of exercise training with conical-PEP for pulmonary rehabilitation (PR) remains limited. This study was conducted to evaluate the aforementioned effects on exercise capacity, DH, and quality of life among patients with moderate to very severe COPD.MethodsForty-two patients with moderate to very severe COPD were assigned to a home-based PR program. They were then randomly allocated to exercise training with conical-PEP (n = 21, age 64.5 ± 6.8 years) or without conical-PEP (control group, n = 21, age 67.2 ± 8.0 years) for 8–10 weeks. The outcomes of the 6-min walk distance (6MWD), the endurance spot marching test (ESMT) for endurance time, an inspiratory capacity (IC) test to assess DH, the transition dyspnea index (TDI), St. George's Respiratory Questionnaire (SGRQ), and the COPD Assessment Test (CAT) were recorded at baseline and at the program's end (post-PR).ResultsThere were no significant differences in 6MWD (p = 0.116) or ESMT endurance time (p = 0.247) between the conical-PEP and control groups at post-PR. Compared to baseline, the post-PR measurements showed a significant reduction in end-exercise IC in the control group (Δ −0.08 L, 95% CI: −0.16 to −0.01 L, p = 0.033) but no significant reduction in the conical-PEP group (Δ −0.07 L, 95% CI: −0.19 to 0.05 L, p = 0.193). No significant differences were found between the groups at post-PR in terms of TDI (p = 0.277), SGRQ (p = 0.687), or CAT (p = 0.704) scores.ConclusionThe addition of conical-PEP during exercise training for PR in COPD did not provide significant benefits over exercise training without conical-PEP. Further research is warranted.

Similar Papers
  • Research Article
  • Cite Count Icon 27
  • 10.1016/s0954-6111(12)70017-3
Psychometric evaluation of the COPD assessment test: Data from the BREATHE study in the Middle East and North Africa region
  • Dec 1, 2012
  • Respiratory Medicine
  • Paul W Jones + 6 more

Psychometric evaluation of the COPD assessment test: Data from the BREATHE study in the Middle East and North Africa region

  • Research Article
  • Cite Count Icon 547
  • 10.1016/s2213-2600(14)70001-3
Minimum clinically important difference for the COPD Assessment Test: a prospective analysis
  • Feb 4, 2014
  • The Lancet Respiratory Medicine
  • Samantha S C Kon + 8 more

The COPD Assessment Test (CAT) is responsive to change in patients with chronic obstructive pulmonary disease (COPD). However, the minimum clinically important difference (MCID) has not been established. We aimed to identify the MCID for the CAT using anchor-based and distribution-based methods. We did three studies at two centres in London (UK) between April 1, 2010, and Dec 31, 2012. Study 1 assessed CAT score before and after 8 weeks of outpatient pulmonary rehabilitation in patients with COPD who were able to walk 5 m, and had no contraindication to exercise. Study 2 assessed change in CAT score at discharge and after 3 months in patients admitted to hospital for more than 24 h for acute exacerbation of COPD. Study 3 assessed change in CAT score at baseline and at 12 months in stable outpatients with COPD. We focused on identifying the minimum clinically important improvement in CAT score. The St George's Respiratory Questionnaire (SGRQ) and Chronic Respiratory Questionnaire (CRQ) were measured concurrently as anchors. We used receiver operating characteristic curves, linear regression, and distribution-based methods (half SD, SE of measurement) to estimate the MCID for the CAT; we included only patients with paired CAT scores in the analysis. In Study 1, 565 of 675 (84%) patients had paired CAT scores. The mean change in CAT score with pulmonary rehabilitation was -2·5 (95% CI -3·0 to -1·9), which correlated significantly with change in SGRQ score (r=0·32; p<0·0001) and CRQ score (r=-0·46; p<0·0001). In Study 2, of 200 patients recruited, 147 (74%) had paired CAT scores. Mean change in CAT score from hospital discharge to 3 months after discharge was -3·0 (95% CI -4·4 to -1·6), which correlated with change in SGRQ score (r=0·47; p<0·0001). In Study 3, of 200 patients recruited, 164 (82%) had paired CAT scores. Although no significant change in CAT score was identified after 12 months (mean 0·6, 95% CI -0·4 to 1·5), change in CAT score correlated significantly with change in SGRQ score (r=0·36; p<0·0001). Linear regression estimated the minimum clinically important improvement for the CAT to range between -1·2 and -2·8 with receiver operating characteristic curves consistently identifying -2 as the MCID. Distribution-based estimates for the MCID ranged from -3·3 to -3·8. The most reliable estimate of the minimum important difference of the CAT is 2 points. This estimate could be useful in the clinical interpretation of CAT data, particularly in response to intervention studies. Medical Research Council and UK National Institute of Health Research.

  • Research Article
  • Cite Count Icon 1
  • 10.12122/j.issn.1673-4254.2021.07.23
Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease
  • Jul 20, 2021
  • Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • Minjia Tan + 4 more

To compare the practicability and clinical value of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease (COPD). We retrospectively analyzed the clinical data of 28 patients with acute exacerbation of COPD admitted to our hospital between November, 2020 and January, 2021. All the patients were assessed with percentage of predicted forced expiratory volume in 1 second (FEV1% pred), COPD assessment test (CAT), modified British Medical Research Council (mMRC), baseline dyspnea index (BDI), clinical COPD questionnaire (CCQ), St. George's respiratory questionnaire (SGRQ), BODE index, Hamilton Depression Rating Scale (HDRS) at admission and with CAT, mMRC, transition dyspnea index (TDI), CCQ, SGRQ, and HDRS at 1 month after discharge. The correlations among FEV1% pred, CAT, mMRC, BDI, CCQ, SGRQ, BODE and HDRS at admission were analyzed. We also compared the TDI and scores of CAT, mMRC, CCQ, SGRQ, and HDRS at 1 month after discharge among the patients using single (n=8), dual (n=10) or triple inhaled medications (n=10) after discharge. Among these patients, FEV1% pred was moderately correlated with SGRQ and BDI (r=-0.66, r=0.61; P < 0.01), and CCQ activity score was closely correlated with mMRC, SGRQ activity score and BDI (r=0.82, r=0.92, r=-0.89; P < 0.01). SGRQ activity score was closely correlated with mMRC and BDI (r=0.84, r=-0.91; P < 0.01), and SGRQ symptom score was closely correlated with BODE (r=0.80, P < 0.01). SGRQ impact score was moderately correlated with HDRS (r=0.57, P < 0.01). In all the 28 patients, all the evaluation scores except for CCQ mental score and HDRS improved significantly after treatment (P < 0.05). At 1 month after discharge, CCQ total score decreased significantly in single therapy group (P < 0.05); CAT, mMRC, CCQ and SGRQ improved obviously in dual therapy group (P < 0.05); CCQ and SGRQ scores decreased significantly in triple therapy group (P < 0.05); the TDI did not differ significantly among the 3 groups (P>0.05). For patients with COPD, BDI and TDI are recommended over mMRC for assessing dyspnea. CAT, CCQ and SGRQ allow sensitive assessment of the treatment efficacy to serve as routine evaluation tests, and among them SGRQ is the most comprehensive and is thus recommended when sufficient time is allowed. BODE is relatively complex but highly valuable for predicting the patients'survival outcomes. HDRS is recommended for routine screening of depression in patients with COPD.

  • Research Article
  • Cite Count Icon 19
  • 10.1002/14651858.cd013384.pub2
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
  • Jul 26, 2021
  • The Cochrane database of systematic reviews
  • Emma J Dennett + 5 more

Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.

  • Research Article
  • Cite Count Icon 3
  • 10.1080/15412555.2021.2013793
Changes in Exercise Capacity and Health-Related Quality of Life at Four and Eight Weeks of a Pulmonary Rehabilitation Program in People with COPD
  • Nov 2, 2021
  • COPD: Journal of Chronic Obstructive Pulmonary Disease
  • Joshua A Bishop + 5 more

Pulmonary Rehabilitation (PR) is a key intervention in the management of people with chronic obstructive pulmonary disease (COPD), though few studies have assessed where changes in outcomes occur during a PR program. The aim of this study was to determine the changes in exercise capacity and health-related quality of life at four and eight weeks during a twice-weekly supervised PR program in people with COPD. Fifty participants with COPD were recruited and attended PR twice-weekly for eight weeks. The outcome measures were the endurance shuttle walk test (ESWT), six-minute walk distance (6MWD), St George’s Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT) and the Hospital Anxiety and Depression Scale (HADS) which were measured at baseline, four and eight weeks. Compared to baseline, at week four there were significant improvements in ESWT (mean difference [95%CI] 197 [89 to 305] seconds), 6MWD (22 [8 to 36] metres), SGRQ symptom score (-6 [-12 to −1] points) and SGRQ total score (-4 [-7 to −1] points). Between week four and eight there were further significant improvements in ESWT (94 [8 to 181] seconds) only. By week eight, ESWT, 6MWD, SGRQ symptoms and total score, and CAT had all improved significantly compared to baseline measures. This study demonstrated that participants with moderate to very severe COPD who participated in a twice weekly, eight-week PR program (16 sessions) had significant improvement in ESWT, 6MWD, SGRQ, and CAT score with the greatest improvements occurring in the first four weeks of the program. Supplemental data for this article is available online at https://doi.org/10.1080/15412555.2021.2013793 .

  • Research Article
  • Cite Count Icon 146
  • 10.1016/j.jamda.2016.08.002
Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis
  • Sep 10, 2016
  • Journal of the American Medical Directors Association
  • Dionne E Smid + 6 more

Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis

  • PDF Download Icon
  • Research Article
  • Cite Count Icon 19
  • 10.3390/jcm8091460
Impact of Disease-Specific Fears on Pulmonary Rehabilitation Trajectories in Patients with COPD
  • Sep 13, 2019
  • Journal of Clinical Medicine
  • Thomas Janssens + 8 more

Disease-specific fears predict health status in chronic obstructive pulmonary disease (COPD), but their role in pulmonary rehabilitation (PR) remains poorly understood and especially longer-term evaluations are lacking. We therefore investigated changes in disease-specific fears over the course of PR and six months after PR, and investigated associations with PR outcomes (COPD assessment test (CAT) and St. Georges respiratory questionnaire (SGRQ)) in a subset of patients with COPD (n = 146) undergoing a 3-week inpatient PR program as part of the STAR study (Clinicaltrials.gov, ID: NCT02966561). Disease-specific fears as measured with the COPD anxiety questionnaire improved after PR. For fear of dyspnea, fear of physical activity and fear of disease progression, improvements remained significant at six-month follow-up. Patients with higher disease-specific fears at baseline showed elevated symptom burden (CAT and SGRQ Symptom scores), which persisted after PR and at follow-up. Elevated disease-specific fears also resulted in reduced improvements in Quality of Life (SGRQ activity and impact scales) after PR and at follow-up. Finally, improvement in disease-specific fears was associated with improvement in symptom burden and quality of life. Adjustment for potential confounding variables (sex, smoking status, age, lung function, and depressive symptoms) resulted in comparable effects. These findings show the role of disease-specific fears in patients with COPD during PR and highlight the need to target disease-specific fears to further improve the effects of PR.

  • PDF Download Icon
  • Research Article
  • Cite Count Icon 5
  • 10.1186/s12955-015-0369-3
A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
  • Oct 31, 2015
  • Health and Quality of Life Outcomes
  • Maggie Tabberer + 2 more

BackgroundChronic obstructive pulmonary disease (COPD) is characterized by non-reversible airflow limitation. A common symptom of COPD is dyspnea or shortness of breath. Dyspnea may vary daily, with a large impact on patients’ lives. Previous clinical trials used patient-reported outcome (PRO) measures that quantified dyspnea at discrete intervals and hence did not reflect this variability. Recently the Shortness of Breath with Daily Activities (SOBDA) questionnaire was developed as a PRO measure of dyspnea utilizing a daily diary. This confirmatory post hoc meta-analysis of SOBDA data from a large clinical study program further supports the questionnaire and clarifies the minimum threshold of SOBDA response.MethodsData from four clinical trials (DB2113361, NCT01313637; DB2113373, NCT01313650; DB2113360, NCT01316900; DB2113374, NCT01316913) were analyzed. These 24-week trials were randomized, blinded studies investigating the efficacy and safety of several COPD treatments. These post hoc analyses focused on the SOBDA questionnaire properties. This electronic-diary consists of 13 items completed daily, in which patients rate their breathlessness level during common daily activities. Resultant SOBDA scores were compared with related, commonly used assessments: modified Medical Research Council Research Dyspnea Scale (mMRC), Baseline Dyspnea Index (BDI), Transition Dyspnea Index (TDI), St George’s Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT), and trough forced expiratory volume in 1 s (FEV1). The consistency, reliability, validity (convergent, known groups), and responsiveness of the SOBDA questionnaire was assessed.ResultsIn total, 4967 patients with COPD provided data for these analyses. The SOBDA questionnaire had high internal consistency (Cronbach’s alpha = 0.936), high test-retest reliability (Pearson’s correlation coefficient = 0.86) and convergent validity with related measures (SGRQ total score, Pearson’s correlation coefficient = 0.59; CAT, Spearman rank-order correlation coefficient = 0.50). SOBDA scores were statistically significantly lower in responders (as defined by TDI, SGRQ, CAT, and trough FEV1 levels) versus non-responders (p < 0.001 for all assessments and all time points). Using an anchor-based method, the threshold of a minimum response was calculated as a SOBDA score change of −0.2 (SOBDA score range = 1–4).ConclusionsThe reliability, validity, and responsiveness of the SOBDA questionnaire as a PRO measure to quantify dyspnea was supported in a large clinical trial population of patients with moderate–very severe COPD.Electronic supplementary materialThe online version of this article (doi:10.1186/s12955-015-0369-3) contains supplementary material, which is available to authorized users.

  • Conference Article
  • Cite Count Icon 1
  • 10.1183/13993003.congress-2016.pa692
New interactive 3D visualization technique used in pulmonary rehabilitation programme in COPD, a randomized controlled study
  • Sep 1, 2016
  • Pernilla Sönnerfors + 4 more

Background: The most common symptoms in chronic obstructive pulmonary disease(COPD) are breathing difficulties and physical activity limitations, reduction in health-related quality of life(HRQL) and exacerbations. Pulmonary rehabilitation including education and exercise training improves health. Interactive 3 dimensional visualization(3D) technique used in patient education has not yet been studied. A new education material with 3D technique was developed to enable an increased personalized education within a group setting. Aim: To evaluate differences between education with 3D technique or conventional technique in patient with COPD regarding physical performance, HRQL and self-efficacy. Method: The pulmonary rehabilitation consisted of exercise training during 10 weeks(10w) and a theoretic part presented with 3D technique or conventional technique. Patients were randomized into education by 3D technique(n=27) or conventional technique(n=16). They were assessed at baseline and after 10w regarding physical performance with handgrip test and 6 minute walk test(6MWT), HRQL with the COPD Assessment Test(CAT) and the St George´s Respiratory Questionnaire(SGRQ), and self-efficacy with the SCI Exercise Self Efficacy Scale(ESES). Result: No significant differences between the groups at baseline or after 10w in 6MWT, CAT, SGRQ or ESES. Significant differences were found in the handgrip test at both baseline(p Conclusion: Interactive 3D technique compared to conventional showed no differences and can be used in pulmonary rehabilitation in COPD. More research is needed, i.e. explore the patient perspective of learning by 3D technique.

  • Research Article
  • Cite Count Icon 41
  • 10.4104/pcrj.2012.00065
Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe.
  • Aug 10, 2012
  • Primary Care Respiratory Journal
  • Paul W Jones + 10 more

Most patients with chronic obstructive pulmonary disease (COPD) in Europe are treated in primary care, but perceptions on what guides primary care physicians (PCPs) in managing patients are lacking. To describe factors associated with the assessment by PCPs of COPD severity and those associated with impaired health status, as assessed by patient-reported outcomes. This cross-sectional study evaluated health-related quality of life (HRQL) in 2,294 COPD patients from five European countries. The severity of COPD was clinically judged by the PCPs and GOLD stage severity was calculated using spirometry data. PCPs' categories of severity reflected a wider range of HRQL scores (St George's Respiratory Questionnaire (SGRQ) total score: mild 30.3; moderate 41.7; severe 55.0; very severe 66.1) than GOLD severity grading (Stage I 38.2; Stage II 41.1; Stage III 49.9; Stage IV 58.5). Multiple ordinal logistic regression models showed that factors most closely related to PCP-rated COPD severity were Medical Research Council (MRC) dyspnoea grade, forced expiratory volume in 1 second (FEV₁) percent predicted, HRQL score (either SGRQ or COPD Assessment Test (CAT)), and previous hospitalisations (model generalised R²=0.45 or 0.44 (SQRQ or CAT in model, respectively); all factors p<0.0001). Factors with the highest association with HRQL scores (SGRQ or CAT) were MRC dyspnoea grade, COPD severity (PCP-rated), sputum production, and number of co-morbidities (model R²=0.46 or 0.37 (SQRQ or CAT in multiple linear regression model, respectively); all factors p<0.0001). PCPs successfully graded COPD severity clinically and appeared to have greater discriminative power for assessing severity in COPD than FEV₁-based staging. Their more holistic approach appeared to reflect the patients' HRQL rating and was consistent across five European countries.

  • Research Article
  • Cite Count Icon 279
  • 10.1136/thx.2010.156372
The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study
  • Mar 12, 2011
  • Thorax
  • J W Dodd + 12 more

BackgroundThe COPD (chronic obstructive pulmonary disease) assessment test (CAT) is a recently introduced, simple to use patient-completed quality of life instrument that contains eight questions covering the impact of symptoms...

  • Abstract
  • 10.1136/thoraxjnl-2012-202678.387
P104 Response of the COPD Assessment Test (CAT) to Pulmonary Rehabilitation in Non-COPD Patients
  • Nov 19, 2012
  • Thorax
  • Ssc Kon + 9 more

BackgroundThe COPD (chronic obstructive pulmonary disease) assessment test (CAT) is a recently introduced, simple to use health status instrument, which takes less time to complete than better-established health status instruments...

  • Research Article
  • Cite Count Icon 69
  • 10.1002/14651858.cd013778.pub2
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
  • Jan 6, 2023
  • The Cochrane database of systematic reviews
  • Omar Ammous + 6 more

IMT may not improve dyspnea, functional exercise capacity and life quality when associated with PR. However, IMT is likely to improve these outcomes when provided alone. For both interventions, a larger effect in participants with respiratory muscle weakness and with longer training durations is still to be confirmed.

  • Research Article
  • Cite Count Icon 44
  • 10.1002/14651858.cd012290.pub2
Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.
  • Oct 10, 2018
  • Cochrane Database of Systematic Reviews
  • Louis Mccusky Gendron + 4 more

Background: Active mind‐body movement therapies (AMBMTs), including but not limited to yoga, tai chi, and qigong, have been applied as exercise modalities for people with chronic obstructive pulmon ...

  • PDF Download Icon
  • Research Article
  • Cite Count Icon 9
  • 10.3389/fresc.2021.729190
Are in Person and Telephone Interviews Equivalent Modes of Administrating the CAT, the FACIT-FS and the SGRQ in People With COPD?
  • Oct 25, 2021
  • Frontiers in Rehabilitation Sciences
  • Vânia Rocha + 3 more

Background: The COVID-19 pandemic brought numerous challenges, namely in routine assessment of people with chronic obstructive pulmonary disease (COPD). The COPD Assessment Test (CAT), the Functional Assessment of Chronic Illness-Fatigue-Subscale (FACIT-FS) and the St. George's respiratory questionnaire (SGRQ) are important patient-reported outcome measures used to assess people with COPD, but its face-to-face application has been compromised. The telephone interview offers a simple and effective alternative, yet uncertainty regarding its equivalence remains. This study aimed to establish the reliability and validity of the CAT, the FACIT-FS and the SGRQ administered by telephone interview in people with COPD.Methods: Data from an observational prospective study including people with COPD were analyzed. Participants answered to the CAT, FACIT-FS and SGRQ questionnaires in person and by telephone, with a maximum interval of 48-h. Participants were randomly selected to answer first to the in-person questionnaire followed by telephone or vice versa. Reliability measures included internal consistency with Cronbach's alpha, test-retest reliability with the intraclass correlation coefficient (ICC2,1), test-retest measurement error with the standard error of measurement (SEM) and agreement with the Bland and Altman 95% limits of agreement. Validity was assessed with the Spearman correlation (rho).Results: Fifty-five people with COPD (44 men; 68.1 ± 7.9 years; FEV1: 59.1 ± 20.3% predicted) were included. Similar internal consistency was observed between in person vs. telephone interview for the CAT (0.82 vs. 0.84), the FACIT-FS (0.83 vs. 0.84) and the SGRQ (0.92 vs. 0.93). Test-retest reliability was excellent, with an ICC2,1 of 0.77 (95% CI: 0.65; 0.86), 0.86 (95% CI: 0.77; 0.92) and 0.94 (95% CI: 0.90; 0.96) for the CAT, FACIT-FS and SGRQ total scores, respectively. The SEM showed a low level of associated measurement error and the Bland and Altman plots illustrated a good level of agreement between both modes of administration, with no evidence of systematic bias. Robust positive correlations (rho 0.87–0.94, p < 0.001) were found for the CAT, FACIT-FS and SGRQ total scores applied by both methods.Conclusion: The telephonic administration of the CAT, the FACIT-FS and the SGRQ are a valid and reliable alternative approach to in person interviews for monitoring symptoms and health-related quality of life in people with COPD. The telephone might be an important add-on for personalized assessment and management of COPD thru remote monitoring.

Save Icon
Up Arrow
Open/Close
  • Ask R Discovery Star icon
  • Chat PDF Star icon

AI summaries and top papers from 250M+ research sources.